Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

KRX/0120G0 stock hub

KRX/0120G0 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KRX/0120G0is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

535.4B

Korea Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

KRX/0120G0

In the news

Latest news · KRX/0120G0

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROICn/a

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KRX/0120G0 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

Groups with data

Currency

KRW

Showing 64 of 64 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Exchange	Korea Stock Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	KRW 535.4B
Price	KRW 72,000
Price currency	KRW
Sic	2834
Symbol	krx/0120G0
Website	https://www.samyangbiopharm.com

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
50-day SMA	91,068
All Time High	150,900
All Time High Change	-52.29%
All Time High Date	2026-03-26
All Time Low	23,250
All Time Low Change	209.68%
All Time Low Date	2025-11-24
ATR	6,325.3
Beta1y	-0.99
Ch YTD	37.14
High	75,900
High52	150,900
High52 Date	2026-03-26
High52ch	-52.29%
Low	71,200
Low52	23,250
Low52 Date	2025-11-24
Low52ch	209.68%
Ma50ch	-20.94%
RSI	37.13
RSI Monthly	0
RSI Weekly	46.58
Sharpe ratio	2.04x
Sortino ratio	3.89
Tr YTD	37.14
Tr1m	-7.1%
Tr1w	-2.17%
Tr3m	-23.08%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,244,460%
Shares Insiders	42.92%
Shares Institutions	12.98%
Shares Out	7,435,870

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	70,799.75x
Ch1m	-7.1
Ch1w	-2.17
Ch3m	-23.08
Change	-1.37%
Change From Open	-1.23
Close	73,000
Days Gap	-0.14
Dollar Volume	2,721,096,000
F Score	0
Founded	2,011
Is Primary Listing	1
Ma20	77,795
Ma20ch	-7.45%
Open	72,900
Position In Range	17.02
Price Date	2026-05-08
Relative Volume	0.53x
Volume	37,793

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does KRX/0120G0 pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns KRX/0120G0?

Insider, institutional, and short-interest positioning.

Institutional ownership

+13.0%

Share of float held by funds and institutions

Insider ownership

+42.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

KRX/0120G0 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

37.1

Neutral momentum band

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

2.04

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KRX/0120G0

Hub-level FAQ points readers to the deeper analysis pages.

What is the current krx/0120G0 stock rating?

krx/0120G0 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full krx/0120G0 analysis?

The full report lives at /stocks/krx/0120G0/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for krx/0120G0?

The latest report frames krx/0120G0 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the krx/0120G0 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.